Skip to main content
Clinical Trials/IRCT20180519039715N3
IRCT20180519039715N3
Recruiting
Phase 1

Determination of effective therapeutic regimen via Levamisole in controlling the idiopathic nephrotic syndrome relapse among children

Kermanshah University of Medical Sciences0 sites188 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Kermanshah University of Medical Sciences
Enrollment
188
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients affliction with steroid\-dependent idiopathic nephrotic syndrome or with high number of relapses
  • 2\-15 years old
  • non\-use of steroid supplementation

Exclusion Criteria

  • Patient treatment with Levamisole for less than 4 months (the minimum follow\-up period)
  • the children’s affliction with any chronic disease other than nephrotic syndrome

Outcomes

Primary Outcomes

Not specified

Similar Trials